Abstract:ABCG2 (ATP-binding cassette, subfamily G, member 2) is a plasma membrane glycoprotein that actively extrudes xenobiotics and endobiotics from the cells and causes multidrug resistance in cancer. In the liver, ABCG2 is expressed in the canalicular membrane of hepatocytes and excretes its substrates into the bile. ABCG2 is known to require high membrane cholesterol content for maximal activity, and by examining purified ABCG2 reconstituted in proteoliposomes we have recently shown that cholesterol is an essential activator, while bile acids significantly modify the activity of this protein. In the present work, by using isolated insect cell membrane preparations expressing human ABCG2 and its mutant variants, we have analyzed whether certain regions in this protein are involved in sterol recognition. We found that replacing ABCG2-R482 with large amino acids does not affect cholesterol dependence, but changes to small amino acids cause altered cholesterol sensitivity. When leucines in the potential steroid-binding element (SBE, aa 555-558) of ABCG2 were replaced by alanines, cholesterol dependence of ABCG2 activity was strongly reduced, although the L558A mutant variant when purified and reconstituted still required cholesterol for full activity. Regarding the effect of bile acids in isolated membranes, we found that these compounds decreased ABCG2-ATPase in the absence of drug substrates, which did not significantly affect substrate-stimulated ATPase activity. These ABCG2 mutant variants also altered bile acid sensitivity, although cholic acid and glycocholate were not transported by the protein. We suggest that the aforementioned two regions in ABCG2 are important for sterol sensing and may represent potential targets for pharmacologic modulation of ABCG2 function.

Role of ABCG5 and ABCG8 in cholesterol transport

Molecular basis of cholesterol efflux via ABCG subfamily transporters

ABCG5/G8 deficiency results in reduced intestinal cholesterol and fatty acid transport

Structural Analysis of Cholesterol Binding and Sterol Selectivity by ABCG5/G8

Snapshots of ABCG1 and ABCG5/G8: A Sterol's Journey to Cross the Cellular Membranes

Relation of ABCG5 and ABCG8 to Formation of Cholesterol Gall Stone

Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice

Structure and transport mechanism of the human cholesterol transporter ABCG1

Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites

Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice

An Evaluation of the Mechanism of Abca7 on Cellular Lipid Release in Abca7-Hec293 Cell

Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization

Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice

Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants

Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9

The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo

Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux

Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion

Alterations of Plasma Lipids in Mice Via Adenoviral-Mediated Hepatic Overexpression of Human ABCA1

FoxO regulates expression of ABCA6, an intracellular ATP-binding-cassette transporter responsive to cholesterol

Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs